EVOK EVOKE PHARMA INC Management Changes 8-K Filing 2024 - Director Appointment Evoke Pharma appointed Benjamin Smeal as a Class II director effective October 18, 2024, with a term expiring at the 2027 annual meeting, and he will serve on various committees.Get access to all SEC 8-K filings of the EVOKE PHARMA INC